Status:
TERMINATED
Treatment of Subclinical Hyperthyroidism
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Subclinical Hyperthyroidism
Atrial Fibrillation
Eligibility:
All Genders
50+ years
Brief Summary
Objective: To determine if the treatment of subclinical hyperthyroidism will reduce the rate of atrial fibrillation, the main complication of this condition.
Detailed Description
Randomized open-labelled multicentre study comparing radioiodine vs medical supervision without treatment
Eligibility Criteria
Inclusion
- Men and women aged 50 and greater
- Isolated decreased thyroid-stimulating hormone (TSH) with normal FT4 and FT3 levels
Exclusion
- Iodide overload
- Non sinusal heart rhythm
- Severe heart disease
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT00213720
Start Date
August 1 2005
End Date
January 1 2020
Last Update
September 29 2020
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Patrick Roger
Bordeaux, France
2
Philippe Thiéblot
Clermont-Ferrand, France
3
Jean-Marcel Brun
Dijon, France
4
Jean-Louis Wemeau
Lille, France